NEUROCRINE BIOSCIENCES INC (NBIX) › Operating IncomeNEUROCRINE BIOSCIENCES INC (NBIX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$53.67M2010: -$13.72M2011: $33.92M2012: $1.45M2013: -$49.68M2014: -$64.41M2015: -$94.20M2016: -$147.37M2017: -$131.36M2018: $36.80M2019: $72.30M2020: $163.00M2021: $102.50M2022: $249.00M2023: $250.90M2024: $570.50M2025: $619.10M$619.10M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$619.10M+8.5%2024$570.50M+127.4%2023$250.90M+0.8%2022$249.00M+142.9%2021$102.50M-37.1%2020$163.00M+125.4%2019$72.30M+96.5%2018$36.80M+128.0%2017-$131.36M+10.9%2016-$147.37M-56.4%2015-$94.20M-46.3%2014-$64.41M-29.7%2013-$49.68M-3530.8%2012$1.45M-95.7%2011$33.92M+347.2%2010-$13.72M+74.4%2009-$53.67M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share